Mon, September 16, 2024
Fri, September 13, 2024
Thu, September 12, 2024
Wed, September 11, 2024
Tue, September 10, 2024

Debjit Chattopadhyay Initiated (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-17-on-sep-12th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Debjit Chattopadhyay of Guggenheim, Initiated "Benitec Biopharma Inc." (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024.

Debjit has made no other calls on BNTC in the last 4 months.



There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Debjit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Debjit


  • Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $13 on, Monday, July 22nd, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024

Publication Contributing Sources